ArticleMicroorganisms2025
Trends in Healthcare-Acquired Infections Due to Multidrug-Resistant Organisms at a German University Medical Center Before and During the COVID-19 Pandemic.
Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Healthcare-associated infections in home care settings: a systematic review of prevalence, risk factors, and prevention strategies.Frontiers in public health · 2026Pooled it
- Environmental Application of Newly Designed Loop-Mediated Isothermal Amplification (LAMP) Kits for Nosocomial Pathogen Detection in Hospital Settings.Life (Basel, Switzerland) · 2026Article
- Two Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- Trends and risk factors of multidrug-resistant hospital-acquired infections in a Tunisian university hospital: repeated point prevalence surveys, 2023-2025.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- Epidemiology and risk factors of multidrug-resistant organisms in a Chinese tertiary hospital: a 10-year retrospective cohort study across the COVID-19 policy phases, 2013-2023.Frontiers in cellular and infection microbiology · 2026Article
- Real-world evidence on predictors of antimicrobial resistance among patients with chronic liver disease.Frontiers in medicine · 2026Article
- Antimicrobial Resistance Trends, Resistance Mechanisms, and Antibiotic Consumption in COVID-19 Versus Non-COVID-19 Units: A Seven-Year Retrospective Cohort Study.Antibiotics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHealthcare-acquired infections due to multidrug-resistant organisms (MDR-HAIs) pose globally significant challenges to healthcare systems, leading to increased morbidity, mortality, and healthcare costs. According to the World Health Organization, the COVID-19 pandemic significantly impacted the burden of MDR-HAIs. The aim of this study was to investigate the dynamics and epidemiology of MDR-HAIs in inpatients at the University of Leipzig Medical Center (ULMC) before and during the COVID-19 pandemic.
methodsWe compared data from inpatients with bacterial infections from 2017 to 2019 (pre-COVID-19) and from 2021to 2023 (during COVID-19) in a cross-sectional, monocentric, retrospective survey. This study focused on selected multidrug-resistant organisms (MDROs) and four clinical specimens. We analyzed the risk factors for MDR-HAIs using logistic regression models.
resultsOut of 342,705 inpatients, 32,206 were diagnosed with a bacterial infection. The prevalence increased significantly from 8.09% (pre-COVID-19) to 10.79% (during COVID-19) (
conclusionThese findings show that it is also important to analyze epidemiological data at the facility level in order to evaluate the effectiveness of infection control practices even during unprecedented health crises like the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.